Literature DB >> 1372451

Sputum sol phase proteins and elastase activity in patients with clinically stable bronchiectasis.

P Lloberes1, E Montserrat, J M Montserrat, C Picado.   

Abstract

BACKGROUND: Inflammatory and proteolytic activity occurs in sputum from patients with stable purulent bronchiectasis and has been proposed as the main pathogenetic mechanism of the disease. This study was designed to define further the role of inflammation and proteolysis in bronchiectasis.
METHODS: Neutrophil elastase activity, sputum concentrations of the serum derived inhibitors alpha 1 antiproteinase and alpha 2 macroglobulin, and the sputum to serum ratios of albumin and C reactive protein concentration were measured in 26 patients with bronchiectasis.
RESULTS: Free elastase activity was found in 15 sputum samples. A trend to higher proteolytic and inflammatory activity was found between mucoid and purulent sputum samples, suggesting that inflammatory and proteolytic activities are related to the macroscopic degree of purulence. Purulent sputum had a high sputum to serum ratio of C reactive protein, suggesting local production or active transport of this protein into bronchial secretions. C reactive protein was more sensitive than albumin in detecting a higher degree of inflammation in elastase positive samples.
CONCLUSION: The finding of greater concentrations of alpha 2 macroglobulin in purulent and elastase positive samples than in mucopurulent, mucoid and elastase negative sputum samples suggests that this inhibitor may have a role in the proteolysis-antiproteolysis balance in bronchial secretions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372451      PMCID: PMC463577          DOI: 10.1136/thx.47.2.88

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  12 in total

1.  Serum derived protease inhibitors and leucocyte elastase in sputum and the effect of infection.

Authors:  R A Stockley; D Burnett
Journal:  Bull Eur Physiopathol Respir       Date:  1980

2.  Degradation of connective tissue components by lung derived leucocytes in vitro: role of proteases and oxidants.

Authors:  G M Brown; K Donaldson
Journal:  Thorax       Date:  1988-02       Impact factor: 9.139

Review 3.  Proteolytic enzymes, their inhibitors and lung diseases.

Authors:  R A Stockley
Journal:  Clin Sci (Lond)       Date:  1983-02       Impact factor: 6.124

4.  Sputum sol-phase proteins and elastase activity in patients with cystic fibrosis.

Authors:  A H Jackson; S L Hill; S C Afford; R A Stockley
Journal:  Eur J Respir Dis       Date:  1984-02

5.  A study of plasma proteins in the sol phase of sputum from patients with chronic bronchitis.

Authors:  R A Stockley; M Mistry; A R Bradwell; D Burnett
Journal:  Thorax       Date:  1979-12       Impact factor: 9.139

6.  Serum amyloid A protein and C-reactive protein levels in pulmonary tuberculosis: relationship to amyloidosis.

Authors:  F C de Beer; A E Nel; R P Gie; P R Donald; A F Strachan
Journal:  Thorax       Date:  1984-03       Impact factor: 9.139

7.  Serum and sputum alpha 2 macroglobulin in patients with chronic obstructive airways disease.

Authors:  D Burnett; R A Stockley
Journal:  Thorax       Date:  1981-07       Impact factor: 9.139

8.  Immunopathology of experimental bronchiectasis.

Authors:  J R Lapa e Silva; D Guerreiro; B Noble; L W Poulter; P J Cole
Journal:  Am J Respir Cell Mol Biol       Date:  1989-10       Impact factor: 6.914

9.  Hyper-alpha-2-macroglobulinemia in narcotic addicts.

Authors:  N F Adham; M K Song; B F Eng
Journal:  Ann Intern Med       Date:  1978-06       Impact factor: 25.391

10.  Effect of bacterial products on human ciliary function in vitro.

Authors:  R Wilson; D Roberts; P Cole
Journal:  Thorax       Date:  1985-02       Impact factor: 9.139

View more
  6 in total

1.  Intravenous immunoglobulin replacement treatment reduces in vivo elastase secretion in patients with common variable immune disorders.

Authors:  Alessandro Prezzo; Filomena M Cavaliere; Cinzia Milito; Caterina Bilotta; Metello Iacobini; Isabella Quinti
Journal:  Blood Transfus       Date:  2018-07-17       Impact factor: 3.443

2.  Presence, activities, and molecular forms of cathepsin G, elastase, alpha 1-antitrypsin, and alpha 1-antichymotrypsin in bronchiectasis.

Authors:  R Sepper; Y T Konttinen; T Ingman; T Sorsa
Journal:  J Clin Immunol       Date:  1995-01       Impact factor: 8.317

Review 3.  Neutrophil elastase in bronchiectasis.

Authors:  Andrea Gramegna; Francesco Amati; Leonardo Terranova; Giovanni Sotgiu; Paolo Tarsia; Daniela Miglietta; Maria Adelaide Calderazzo; Stefano Aliberti; Francesco Blasi
Journal:  Respir Res       Date:  2017-12-19

Review 4.  Understanding the role of neutrophils in chronic inflammatory airway disease.

Authors:  Alice E Jasper; William J McIver; Elizabeth Sapey; Georgia M Walton
Journal:  F1000Res       Date:  2019-04-26

5.  The immune response and its therapeutic modulation in bronchiectasis.

Authors:  Massoud Daheshia; James D Prahl; Jacob J Carmichael; John S Parrish; Gilbert Seda
Journal:  Pulm Med       Date:  2012-10-10

Review 6.  The Role of the Immune Response in the Pathogenesis of Bronchiectasis.

Authors:  Paul T King
Journal:  Biomed Res Int       Date:  2018-03-18       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.